Pular para o conteúdo
Merck
Todas as fotos(2)

Documentos Principais

Visualizar Toda a Documentação

GF64303455

Bismuth

foil, not light tested, 100x100mm, thickness 0.05mm, permanent polyester support, 99.97%

Sinônimo(s):

Bismuth, BI000190

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(2)

About This Item

Fórmula empírica (Notação de Hill):
Bi
Número CAS:
7440-69-9
Peso molecular:
208.98
Número MDL:
MFCD00134033
Código UNSPSC:
12141706
ID de substância PubChem:
329809700
NACRES:
NA.23

pressão de vapor

<0.1 mmHg ( 20 °C)

Ensaio

99.97%

Formulário

foil

fabricante/nome comercial

Goodfellow 643-034-55

resistividade

129 μΩ-cm, 20°C

tamanho × espessura

100x100 mm × 0.05 mm

p.e.

1560 °C (lit.)

pf

271 °C (lit.)

densidade

9.8 g/mL at 25 °C (lit.)

cadeia de caracteres SMILES

[Bi]

InChI

1S/Bi

chave InChI

JCXGWMGPZLAOME-UHFFFAOYSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

For updated SDS information please visit www.goodfellow.com.

Informações legais

Product of Goodfellow

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials
Andreia M C Rocha et al.
British journal of haematology, 168(3), 421-428 (2014-09-27)
Helicobacter pylori eradication induces platelet recovery in a subgroup of patients with chronic immune thrombocytopenia (cITP), but the mechanisms involved are still not understood. We aimed to evaluate the effect of H. pylori eradication on platelet response and to identify the
Javier P Gisbert et al.
Helicobacter, 10(3), 157-171 (2005-05-21)
To systematically review the Helicobacter pylori eradication efficacy with ranitidine bismuth citrate (RBC) and two antibiotics, and to conduct a meta-analysis of randomized clinical trials comparing the efficacy of proton pump inhibitor (PPI) vs. RBC with two antibiotics for 1
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica